These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons. Caudal D, Alvarsson A, Björklund A, Svenningsson P. Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495 [Abstract] [Full Text] [Related]
31. Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans. Kuwahara T, Koyama A, Gengyo-Ando K, Masuda M, Kowa H, Tsunoda M, Mitani S, Iwatsubo T. J Biol Chem; 2006 Jan 06; 281(1):334-40. PubMed ID: 16260788 [Abstract] [Full Text] [Related]
32. α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease. Chu Y, Mickiewicz AL, Kordower JH. Neurobiol Dis; 2011 Jan 06; 41(1):71-82. PubMed ID: 20816781 [Abstract] [Full Text] [Related]
33. Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Junn E, Mouradian MM. Neurosci Lett; 2002 Mar 08; 320(3):146-50. PubMed ID: 11852183 [Abstract] [Full Text] [Related]
34. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease. Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA. Neurobiol Dis; 2005 Apr 08; 18(3):492-8. PubMed ID: 15755676 [Abstract] [Full Text] [Related]
35. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease. Febbraro F, Sahin G, Farran A, Soares S, Jensen PH, Kirik D, Romero-Ramos M. Neurobiol Dis; 2013 Aug 08; 56():47-58. PubMed ID: 23567651 [Abstract] [Full Text] [Related]
37. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Maingay M, Romero-Ramos M, Carta M, Kirik D. Neurobiol Dis; 2006 Sep 08; 23(3):522-32. PubMed ID: 16806952 [Abstract] [Full Text] [Related]
38. Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease. Brys I, Nunes J, Fuentes R. Eur J Neurosci; 2017 Aug 08; 46(3):1906-1917. PubMed ID: 28370471 [Abstract] [Full Text] [Related]
39. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression. Bourdenx M, Dovero S, Engeln M, Bido S, Bastide MF, Dutheil N, Vollenweider I, Baud L, Piron C, Grouthier V, Boraud T, Porras G, Li Q, Baekelandt V, Scheller D, Michel A, Fernagut PO, Georges F, Courtine G, Bezard E, Dehay B. Acta Neuropathol Commun; 2015 Jul 25; 3():46. PubMed ID: 26205255 [Abstract] [Full Text] [Related]
40. Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. Taschenberger G, Garrido M, Tereshchenko Y, Bähr M, Zweckstetter M, Kügler S. Acta Neuropathol; 2012 May 25; 123(5):671-83. PubMed ID: 22167382 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]